GPC3 and hepatocellular carcinoma: In the same context, Zhuo et al. [30] used GPC3 expression and KI67LI to predict hepatocellular carcinoma PDX engraftment and found a good discriminatory power (AUC 0.828), which is similar to the score obtained in the current study.